The course of infection caused by Encephalitozoon cuniculi genotype III in immunocompetent and immunodeficient mice

Michaela Kotková1, Bohumil Sak2, Lenka Hlásková2

  • 1Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic; Faculty of Agriculture, University of South Bohemia in České Budějovice, České Budějovice, Czech Republic.

Experimental Parasitology
|September 25, 2017
PubMed

Insights

Encephalitozoon cuniculi genotype III causes severe infections in both healthy and immunocompromised hosts. Treatment with albendazole showed limited effectiveness, highlighting the importance of host immunity and parasite genotype in disease progression.

Area of Science:

  • Veterinary Parasitology
  • Immunology
  • Microbiology

Background:

  • Encephalitozoon cuniculi is a common microsporidian parasite infecting diverse vertebrates, including humans.
  • Four genotypes of E. cuniculi have been identified based on rRNA internal transcribed spacer variations.

Purpose of the Study:

  • To investigate the course of infection and treatment response of Encephalitozoon cuniculi genotype III in different host models.
  • To understand the influence of host immunological status and parasite genotype on encephalitozoonosis.

Main Methods:

  • Experimental infection of immunocompetent BALB/c mice and immunocompromised SCID mice with E. cuniculi III.
  • Assessment of parasite dissemination in organs and tissues.
  • Evaluation of the therapeutic effect of albendazole.

Main Results:

  • E. cuniculi III caused rapid and widespread infection in all organs within one week in immunocompetent hosts.
  • In immunocompromised SCID mice, infection with E. cuniculi III led to rapid dissemination and host death.
  • Experimental treatment with albendazole demonstrated minimal efficacy in immunocompetent mice.

Conclusions:

  • The course of E. cuniculi infection and response to albendazole are significantly influenced by both the host's immunological status and the parasite's genotype.
  • Findings are critical for managing infections in immunocompromised individuals, such as chemotherapy patients and organ transplant recipients.

Related Concept Videos